Company Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-21 pm EST			5-day change	1st Jan Change
78.94 ^USD	+1.56%		+3.51%	+4.45%

Jan. 20	Mizuho Adjusts Price Target on Henry Schein to $81 From $74, Maintains Neutral Rating	MT
Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT

Business description: Henry Schein, Inc.

Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows:

- distribution of health care products and equipment (83.8%): dental products and equipment (62.1% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (37.9%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.);

- other (16.2%): sale and integration of management software, financial, training, maintenance and equipment repair services.

The United States account for 69.5% of net sales.

Number of employees: 25,000

Sales by Activity: Henry Schein, Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Global Distribution and Value-added Services	-	-	-	-	10.76B
Health Care Distribution	9.53B	11.76B	11.92B	11.53B	-
Global Specialty Products	-	-	-	-	1.45B
Global Technology	-	-	-	-	630M
Technology and Value-Added Services	514M	641M	723M	806M	-
Corporate TSA Revenues	75.27M	-	-	-	-
Eliminations	-	-	-	-	-163M

See all business segments

Geographical breakdown of sales: Henry Schein, Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States	7.09B	8.72B	9.19B	8.63B	8.8B
International	3.03B	3.68B	3.46B	3.71B	3.87B

See all geographic segments

Executive Committee: Henry Schein, Inc.

Manager	Title	Age	Since
Stanley Bergman CEO	Chief Executive Officer	76	1988-12-31
Ronald South DFI	Director of Finance/CFO	64	2022-04-28
Christopher Pendergast CTO	Chief Tech/Sci/R&D Officer	63	2018-03-31
Michael Ettinger COO	Chief Operating Officer	65	2022-06-30
Graham Barry Stanley IRC	Investor Relations Contact	58	2003-12-31

See HENRY SCHEIN, INC. governance

Composition of the Board of Directors: Henry Schein, Inc.

Director	Title	Age	Since
Stanley Bergman CHM	Chairman	76	1988-12-31
Philip Laskaway BRD	Director/Board Member	83	2002-01-31
Bradley Sheares BRD	Director/Board Member	69	2010-01-19
Joseph Herring BRD	Director/Board Member	70	2016-05-30
Kurt Kuehn BRD	Director/Board Member	71	2016-05-31
Anne Margulies BRD	Director/Board Member	70	2018-05-30
Mohamad Ali BRD	Director/Board Member	55	2021-02-08
Deborah Derby BRD	Director/Board Member	62	2021-02-08
Reed Tuckson BRD	Director/Board Member	75	2021-05-16
Scott Serota BRD	Director/Board Member	69	2021-12-06

Composition of the Board of Directors

Shareholders: Henry Schein, Inc.

Name	Equities	%	Valuation
Kohlberg Kravis Roberts & Co. LP 15.23 %	17,934,348	15.23 %	1 355 M $
The Vanguard Group, Inc. 10.22 %	12,036,336	10.22 %	910 M $
Vanguard Fiduciary Trust Co. 10.19 %	12,000,776	10.19 %	907 M $
Artisan Partners Holdings LP 5.804 %	6,833,041	5.804 %	516 M $
JPMorgan Investment Management, Inc. 5.274 %	6,208,770	5.274 %	469 M $

List of HENRY SCHEIN, INC. shareholders

Company details: Henry Schein, Inc.

Henry Schein, Inc.

135 Duryea Road

11747, Melville

+631 843 5500

http://www.henryschein.com

Group companies: Henry Schein, Inc.

Name	Category and Sector
Jørgen Kruuse A/S Jørgen Kruuse A/S Medical DistributorsDistribution Services Supplies veterinary products	Medical Distributors
ABIC Polska Sp zoo
Medivet SA Medivet SA Wholesale DistributorsDistribution Services Distributes animal health products and services	Wholesale Distributors
Henry Schein European Holding BV Henry Schein European Holding BV Henry Schein European Holding BV is a Dutch healthcare solutions company specializing in the distribution of medical and dental products, services, and technologies. The company is based in Almere, the Netherlands. The company serves over one million customers worldwide across 33 countries, operating 58 distribution and manufacturing centers. Its portfolio includes more than 300,000 products such as vaccines, pharmaceuticals, dental implants, orthodontic devices, and advanced clinical and digital technologies like CAD/CAM equipment and imaging systems. Henry Schein supports healthcare professionals with business, clinical, technology, and supply chain solutions, and provides educational resources and innovations for dental professionals.
Alphadent NV

See all subsidiaries

Medical Equipment Wholesale

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
HENRY SCHEIN, INC.	+1.56%	+3.51%	+6.40%	-2.37%	9.29B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	+1.54%	-5.28%	-	-	1.88B
SHIP HEALTHCARE HOLDINGS, INC.	-0.20%	-0.54%	+24.74%	+5.40%	1.56B
AS ONE CORPORATION	+1.64%	-2.23%	-1.99%	-15.11%	1.07B
COWEALTH MEDICAL CHINA CO.,LTD.	-2.31%	-13.32%	+155.32%	+52.66%	1.02B
GKHT MEDICAL TECHNOLOGY CO., LTD.	+0.08%	-3.43%	+17.70%	-	811M
EXCELSIOR MEDICAL CO., LTD.	-0.63%	-1.25%	-3.56%	+30.48%	428M
WIN-PARTNERS CO., LTD.	+0.82%	-1.81%	+4.46%	+36.21%	237M
NIPPON CARE SUPPLY CO., LTD.	+0.46%	+0.46%	+23.95%	+53.56%	234M
Average	+0.33%	-1.09%	+28.38%	+22.98%	1.84B
Weighted average by Cap.	+1.00%	+1.22%	+18.65%	+4.18%